Impact of allogeneic hematopoietic cell transplantation (HCT) as consolidation following CD19 chimeric antigen receptor (CAR) T cell therapy for treatment of relapsed acute lymphoblastic leukemia (ALL) Meeting Abstract

  

Authors:	Park, J. H.; Nikiforow, S.; Kim, S.; Hu, Z. H.; Moskop, A.; Ahmed, S.; Abid, M. B.; Badar, T.; Bredeson, C.; Brown, V.; Cairo, M. S.; Díaz, M.; Dholaria, B.; Ganguly, S.; Grover, N. S.; Hanna, R.; Hematti, P.; Kohorst, M. A.; Lazarus, H.; Lekakis, L. J.; Locke, F. L.; Murthy, H. S.; Mussetti, A.; Pulsipher, M. A.; Qayed, M.; Reshef, R.; Rizzieri, D. A.; Salas, M. Q.; Savani, B. B.; Sharma, A.; Schultz, K. R.; Thakar, M.; Turtle, C.; Yared, J. A.; Wagner, J. L.; Qiu, X.; Pasquini, M. C.; Perales, M. A.
Abstract Title:	Impact of allogeneic hematopoietic cell transplantation (HCT) as consolidation following CD19 chimeric antigen receptor (CAR) T cell therapy for treatment of relapsed acute lymphoblastic leukemia (ALL)
Meeting Title:	63rd Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	138
Issue:	Suppl. 1
Meeting Dates:	2021 Dec 11-14
Meeting Location:	Atlanta, GA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2021-11-23
Language:	English
ACCESSION:	WOS:000736413908005
DOI:	10.1182/blood-2021-148652
PROVIDER:	wos
Notes:	Meeting Abstract: 3880 -- Hybrid meeting, also took place online -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/198904